-
1
-
-
34247276003
-
Satisfaction with current migraine therapy: Experience from 3 centers in us and sweden
-
Bigal M, Rapoport A,Aurora S, Sheftell F,Tepper S, Dahlof C. Satisfaction with current migraine therapy: Experience from 3 centers in US and Sweden. Headache. 2007;47: 475-479.
-
(2007)
Headache
, vol.47
, pp. 475-479
-
-
Bigal, M.1
Rapoport, A.2
Aurora, S.3
Sheftell, F.4
Tepper, S.5
Dahlof, C.6
-
3
-
-
33746307867
-
Which triptan for which patient?
-
Rapoport AM, Tepper SJ, Sheftell FD, Kung E, Bigal ME. Which triptan for which patient? Neurol Sci. 2006;27(Suppl. 2): S123-S129.
-
(2006)
Neurol Sci
, vol.27
, Issue.SUPPL. 2
-
-
Rapoport, A.M.1
Tepper, S.J.2
Sheftell, F.D.3
Kung, E.4
Bigal, M.E.5
-
4
-
-
0036839151
-
Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers
-
Yates R, Nairn K, Dixon R, Kemp JV, Dane AL. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers. J Clin Pharmacol. 2002;42: 1244-1250.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 1244-1250
-
-
Yates, R.1
Nairn, K.2
Dixon, R.3
Kemp, J.V.4
Dane, A.L.5
-
5
-
-
0036838322
-
Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers
-
Yates R, Nairn K, Dixon R, Seaber E. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. J Clin Pharmacol. 2002;42: 1237-1243.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 1237-1243
-
-
Yates, R.1
Nairn, K.2
Dixon, R.3
Seaber, E.4
-
6
-
-
16244362023
-
Bioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy japanese subjects
-
Uemura N, Onishi T, Mitaniyama A, et al. Bioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy Japanese subjects. Clin Drug Investig. 2005;25: 199-208.
-
(2005)
Clin Drug Investig
, vol.25
, pp. 199-208
-
-
Uemura, N.1
Onishi, T.2
Mitaniyama, A.3
-
7
-
-
22244483918
-
Distribution of intranasal c-zolmitriptan assessed by positron emission tomography
-
Yates R, Sorensen J, Bergstrom M, et al. Distribution of intranasal C-zolmitriptan assessed by positron emission tomography. Cephalalgia. 2005; 25: 1103-1109.
-
(2005)
Cephalalgia
, vol.25
, pp. 1103-1109
-
-
Yates, R.1
Sorensen, J.2
Bergstrom, M.3
-
8
-
-
33645890579
-
Blood-brain barrier penetration of zolmitriptan -modelling of positron emission tomography data
-
Bergstrom M,Yates R,Wall A, Kagedal M, Syvanen S, Langstrom B. Blood-brain barrier penetration of zolmitriptan -Modelling of positron emission tomography data. J Pharmacokinet Pharmacodyn. 2006;33: 75-91.
-
(2006)
J Pharmacokinet Pharmacodyn
, vol.33
, pp. 75-91
-
-
Bergstrom, M.1
Yates, R.2
Wall, A.3
Kagedal, M.4
Syvanen, S.5
Langstrom, B.6
-
9
-
-
22244480049
-
Distribution of zolmitriptan into the cns in healthy volunteers: A positron emission tomography study
-
Wall A, Kagedal M, Bergstrom M, et al. Distribution of zolmitriptan into the CNS in healthy volunteers: A positron emission tomography study. Drugs R D. 2005;6: 139-147.
-
(2005)
Drugs R D
, vol.6
, pp. 139-147
-
-
Wall, A.1
Kagedal, M.2
Bergstrom, M.3
-
10
-
-
11844255513
-
True nasopharyngeal absorption of zolmitriptan following administration of zolmitriptan nasal spray [abstract]
-
Zingmark P-H, Yates R, Hedlund C, Kågedal M. True nasopharyngeal absorption of zolmitriptan following administration of zolmitriptan nasal spray [abstract]. Cephalalgia. 2003;23: 700.
-
(2003)
Cephalalgia
, vol.23
, pp. 700
-
-
Zingmark, P.-H.1
Yates, R.2
Hedlund, C.3
Kågedal, M.4
-
12
-
-
33645109046
-
Zolmitriptan intranasal: A review of the pharmacokinetics and clinical efficacy
-
Goadsby PJ, Yates R. Zolmitriptan intranasal: A review of the pharmacokinetics and clinical efficacy. Headache. 2006;46: 138-149.
-
(2006)
Headache
, vol.46
, pp. 138-149
-
-
Goadsby, P.J.1
Yates, R.2
-
13
-
-
37348999890
-
Clinical pharmacology of the serotonin receptor agonist, zolmitriptan
-
Peterlin BL, Rapoport AM. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol. 2007;3: 899-911.
-
(2007)
Expert Opin Drug Metab Toxicol
, vol.3
, pp. 899-911
-
-
Peterlin, B.L.1
Rapoport, A.M.2
-
14
-
-
0030859745
-
The clinical pharmacokinetics of zolmitriptan
-
Dixon R,Warrander A. The clinical pharmacokinetics of zolmitriptan. Cephalalgia. 1997;17(Suppl. 18): 15-20.
-
(1997)
Cephalalgia
, vol.17
, Issue.SUPPL. 18
, pp. 15-20
-
-
Dixon, R.1
Warrander, A.2
-
15
-
-
0036020407
-
The pharmacokinetics of the antimigraine compound zolmitriptan in japanese and caucasian subjects
-
Yates RA, Tateno M, Nairn K, Ikegami A, Dane A, Kemp J. The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. Eur J Clin Pharmacol. 2002;58: 247-252.
-
(2002)
Eur J Clin Pharmacol
, vol.58
, pp. 247-252
-
-
Yates, R.A.1
Tateno, M.2
Nairn, K.3
Ikegami, A.4
Dane, A.5
Kemp, J.6
-
16
-
-
0041592746
-
Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet
-
Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Farkkila M. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. CNS Drugs. 2003;17: 653-667.
-
(2003)
CNS Drugs
, vol.17
, pp. 653-667
-
-
Charlesworth, B.R.1
Dowson, A.J.2
Purdy, A.3
Becker, W.J.4
Boes-Hansen, S.5
Farkkila, M.6
-
17
-
-
0042333258
-
Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial
-
Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Farkkila M. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. CNS Drugs. 2003;17: 839-851.
-
(2003)
CNS Drugs
, vol.17
, pp. 839-851
-
-
Dowson, A.J.1
Charlesworth, B.R.2
Purdy, A.3
Becker, W.J.4
Boes-Hansen, S.5
Farkkila, M.6
-
18
-
-
14644391549
-
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled study
-
Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled study. CNS Drugs. 2005;19: 125-136.
-
(2005)
CNS Drugs
, vol.19
, pp. 125-136
-
-
Dodick, D.1
Brandes, J.2
Elkind, A.3
Mathew, N.4
Rodichok, L.5
-
19
-
-
11844270394
-
Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: Results of the index trial
-
Dowson AJ, Charlesworth BR, Green J, et al. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: Results of the INDEX trial. Headache. 2005;45: 17-24.
-
(2005)
Headache
, vol.45
, pp. 17-24
-
-
Dowson, A.J.1
Charlesworth, B.R.2
Green, J.3
-
20
-
-
11844253775
-
Zolmitriptan 5 mg nasal spray: Efficacy and onset of action in the acute treatment of migraine -results from phase 1 of the realize study
-
Gawel M, Aschoff J, May A, Charlesworth BR. Zolmitriptan 5 mg nasal spray: Efficacy and onset of action in the acute treatment of migraine -Results from phase 1 of the REALIZE Study. Headache. 2005;45: 7-16.
-
(2005)
Headache
, vol.45
, pp. 7-16
-
-
Gawel, M.1
Aschoff, J.2
May, A.3
Charlesworth, B.R.4
-
21
-
-
33846087513
-
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: Results of a postmarketing surveillance study
-
Diener HC, Evers S. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: Results of a postmarketing surveillance study. Clin Drug Investig. 2007;27: 59-66.
-
(2007)
Clin Drug Investig
, vol.27
, pp. 59-66
-
-
Diener, H.C.1
Evers, S.2
-
22
-
-
84874828795
-
Migraine therapeutics in adolescents: A systematic analysis and historic perspectives of triptan trials in adolescents
-
Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: A systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr. 2013;167: 243-249.
-
(2013)
JAMA Pediatr
, vol.167
, pp. 243-249
-
-
Sun, H.1
Bastings, E.2
Temeck, J.3
-
24
-
-
34548258794
-
Zolmitriptan nasal spray in the acute treatment of cluster headache: A double-blind study
-
Rapoport AM, Mathew NT, Silberstein SD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: A double-blind study. Neurology. 2007;69: 821-826.
-
(2007)
Neurology
, vol.69
, pp. 821-826
-
-
Rapoport, A.M.1
Mathew, N.T.2
Silberstein, S.D.3
-
25
-
-
33750626423
-
Effectiveness of intranasal zolmitriptan in acute cluster headache: A randomized, placebocontrolled, double-blind crossover study
-
Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: A randomized, placebocontrolled, double-blind crossover study. Arch Neurol. 2006;63: 1537-1542.
-
(2006)
Arch Neurol
, vol.63
, pp. 1537-1542
-
-
Cittadini, E.1
May, A.2
Straube, A.3
Evers, S.4
Bussone, G.5
Goadsby, P.J.6
-
26
-
-
70349905236
-
Zolmitriptan nasal spray in the acute treatment of cluster headache: A meta-analysis of two studies
-
Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ. Zolmitriptan nasal spray in the acute treatment of cluster headache: A meta-analysis of two studies. Headache. 2009;49: 1315-1323.
-
(2009)
Headache
, vol.49
, pp. 1315-1323
-
-
Hedlund, C.1
Rapoport, A.M.2
Dodick, D.W.3
Goadsby, P.J.4
-
27
-
-
28444452264
-
Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: Results from phase two of the realize study
-
Gawel M, Aschoff J, May A, Charlesworth BR. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: Results from phase two of the REALIZE study. J Headache Pain. 2005;6: 405-411.
-
(2005)
J Headache Pain
, vol.6
, pp. 405-411
-
-
Gawel, M.1
Aschoff, J.2
May, A.3
Charlesworth, B.R.4
-
28
-
-
34648818989
-
Patient preference for triptan formulations: A prospective study with zolmitriptan
-
Dowson A, Bundy M, Salt R, Kilminster S. Patient preference for triptan formulations: A prospective study with zolmitriptan. Headache. 2007;47: 1144-1151.
-
(2007)
Headache
, vol.47
, pp. 1144-1151
-
-
Dowson, A.1
Bundy, M.2
Salt, R.3
Kilminster, S.4
-
29
-
-
10044225588
-
Migraine treatment strategies: The global migraine and zolmitriptan evaluation (maze) survey -phase iv
-
MacGregor EA, Brandes J, Gendolla A, Giammarco R. Migraine treatment strategies: The global Migraine And Zolmitriptan Evaluation (MAZE) survey -Phase IV. Curr Med Res Opin. 2004;20: 1777-1783.
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 1777-1783
-
-
MacGregor, E.A.1
Brandes, J.2
Gendolla, A.3
Giammarco, R.4
-
30
-
-
31244431881
-
Treatment preferences and the selection of acute migraine medications: Results from a population-based survey
-
Lipton RB, Liberman J, Cutrer FM, et al. Treatment preferences and the selection of acute migraine medications: Results from a population-based survey. J Headache Pain. 2004;5: 123-130.
-
(2004)
J Headache Pain
, vol.5
, pp. 123-130
-
-
Lipton, R.B.1
Liberman, J.2
Cutrer, F.M.3
-
31
-
-
0036169984
-
What do patients with migraine want from acute migraine treatment?
-
Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache. 2002;42(Suppl. 1): 3-9.
-
(2002)
Headache
, vol.42
, Issue.SUPPL. 1
, pp. 3-9
-
-
Lipton, R.B.1
Hamelsky, S.W.2
Dayno, J.M.3
-
32
-
-
0033404903
-
Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
-
Lipton RB, Stewart WF. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache. 1999;39(Suppl. 2): S20-S26.
-
(1999)
Headache
, vol.39
, Issue.SUPPL. 2
-
-
Lipton, R.B.1
Stewart, W.F.2
-
33
-
-
16844386298
-
How treatment priorities influence triptan preferences in clinical practice: Perspectives of migraine sufferers, neurologists, and primary care physicians
-
Lipton RB, Cutrer FM, Goadsby PJ, et al. How treatment priorities influence triptan preferences in clinical practice: Perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin. 2005;21: 413-424.
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 413-424
-
-
Lipton, R.B.1
Cutrer, F.M.2
Goadsby, P.J.3
-
34
-
-
0031658863
-
Migraine chronobiology
-
Fox AW, Davis RL. Migraine chronobiology. Headache. 1998;38: 436-441.
-
(1998)
Headache
, vol.38
, pp. 436-441
-
-
Fox, A.W.1
Davis, R.L.2
|